Does This 57-Year-Old Black Man Have CKD?
You cannot determine if this patient has chronic kidney disease without laboratory testing—specifically, you need to measure his estimated glomerular filtration rate (eGFR) and urine albumin-to-creatinine ratio (UACR).
Diagnostic Criteria for CKD
According to established guidelines, CKD is defined as either kidney damage OR decreased kidney function (eGFR <60 mL/min/1.73 m²) persisting for 3 or more months 1.
Required Laboratory Tests
To diagnose CKD, you must obtain:
- Serum creatinine to calculate eGFR using the race-free CKD-EPI equation (the current standard as of 2022) 2
- Spot urine albumin-to-creatinine ratio (UACR) 3, 4
Diagnostic Thresholds
Kidney damage markers:
- UACR >30 mg/g indicates albuminuria (>17 mg/g for men using sex-specific cutpoints) 1
- Other markers include abnormal urine sediment, blood/urine chemistry abnormalities, or imaging findings 1
Decreased kidney function:
- eGFR <60 mL/min/1.73 m² represents loss of half or more of normal kidney function 1
- This threshold marks the point where CKD complications increase substantially 1
Critical Timing Requirement
A single abnormal test does NOT establish CKD diagnosis. You must document persistence of abnormalities for ≥3 months through repeat testing 1. This distinguishes chronic from acute kidney injury.
Special Considerations for Black Patients
Race-Free eGFR Calculation
The 2022 NKF-ASN Task Force recommended eliminating race from GFR estimation equations 2. Use the CKD-EPI 2021 race-free equation or the CKD-EPI creatinine-cystatin C equation for most accurate assessment.
Important caveat: The race-free equation may underestimate GFR in some Black patients by approximately 3.6 mL/min/1.73 m² compared to the older race-based equation 5. This means some Black patients previously classified as not having CKD may now meet diagnostic criteria 2.
Epidemiologic Context
Black adults face disproportionate CKD burden:
- 20.9% prevalence of CKD among Black adults versus 14.7% among White adults 6
- 3-5 times higher risk of progression to end-stage kidney disease 7
- CKD is associated with increased all-cause mortality in older Black adults 8
- At age 57, approximately 17% of adults >60 years have eGFR <60 mL/min/1.73 m² 1
Clinical Algorithm
Step 1: Order serum creatinine and spot UACR
Step 2: Calculate eGFR using race-free CKD-EPI equation
Step 3: Interpret results:
- If eGFR ≥60 AND UACR <30 mg/g → No CKD (assuming no other kidney damage markers)
- If eGFR <60 OR UACR ≥30 mg/g → Repeat testing in 3 months
Step 4: If abnormalities persist ≥3 months → CKD diagnosis confirmed
Step 5: Stage CKD based on eGFR and albuminuria categories 3, 9
Why This Matters for Mortality and Morbidity
Even without symptoms, decreased eGFR is an independent predictor of death and cardiovascular disease in all age groups, including those >60 years 1. The definition of CKD remains the same regardless of age 1.
Patients with CKD should be considered in the highest risk group for cardiovascular events 1. Early detection enables:
- Prevention or delay of complications (hypertension, anemia, bone disease, cardiovascular disease) 1
- Slowing progression to kidney failure 1
- Appropriate medication dosing adjustments 1
- Timely nephrology referral when eGFR <30 mL/min/1.73 m² 3
Bottom line: You cannot answer whether this patient has CKD without laboratory data showing persistent abnormalities over ≥3 months. Order the tests now.